SR 4835
CAS: 2387704-62-1
Ref. 3D-BS180614
| 5mg | 217.00 € | ||
| 10mg | 325.00 € | ||
| 25mg | 452.00 € | ||
| 50mg | 723.00 € | ||
| 100mg | 1,136.00 € |
Product Information
SR 4835 is a cytostatic drug that inhibits the transcriptional regulation of cancer cells. It has been shown to have clinical efficacy in prostate cancer, which is resistant to androgen deprivation therapy. SR 4835 also activates the response pathway by inhibiting the production of proteins that are essential for tumor growth. The mouse tumor model studies showed an antitumor response when SR 4835 was administered intraperitoneally, with a significant decrease in body weight. This drug also has prognostic value, as it predicts a better outcome after radical prostatectomy in patients with prostate cancer. SR 4835 is effective in the treatment of human protein-related cancers such as thz531 and repair mechanism.
Chemical properties
Technical inquiry about: 3D-BS180614 SR 4835
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
